What is ClickDiagnostics?
ClickDiagnostics operates at the intersection of mobile telecommunications and medical diagnostics. The company provides a comprehensive platform that connects patients in underserved regions with medical professionals, facilitating remote consultations and medical record analysis. By integrating with existing public health infrastructure, the firm enables governments and NGOs to perform effective health interventions through real-time data analytics. This approach addresses the global disparity in healthcare access, transforming mobile devices into essential diagnostic tools that support clinical decision-making and patient history management.
How much funding has ClickDiagnostics raised?
ClickDiagnostics has raised a total of $196.3M across 4 funding rounds:
Series A
$16M
Debt
$9.5M
Series B
$100.8M
Series C
$70M
Series A (2015): $16M, investors not publicly disclosed
Debt (2018): $9.5M, investors not publicly disclosed
Series B (2020): $100.8M, investors not publicly disclosed
Series C (2020): $70M featuring Pitango Venture Capital, Cedars-Sinai, and John Doerr
Key Investors in ClickDiagnostics
Pitango Venture Capital
Pitango is a venture capital firm that partners with visionary entrepreneurs and groundbreaking companies, supporting them from stealth mode to maturity with a specific focus on HealthTech innovation.
Cedars-Sinai
A leading non-profit academic medical center in the U.S. that provides clinical programs ranging from primary care to specialized treatments for complex illnesses.
John Doerr
A prominent venture capitalist and investor known for supporting high-growth technology companies and transformative digital health initiatives.
What's next for ClickDiagnostics?
With the recent influx of capital, ClickDiagnostics is poised to transition from a scaling enterprise to a dominant force in the digital health sector. The strategic focus will likely shift toward enhancing the interoperability of its medical record analysis features and expanding its footprint in emerging markets where mobile penetration is high but medical infrastructure remains fragmented. By deepening partnerships with academic medical centers and venture-backed health-tech innovators, the company is well-positioned to refine its diagnostic algorithms and solidify its role as a primary conduit for global health data, ultimately driving long-term value for stakeholders and improving patient outcomes on a global scale.
See full ClickDiagnostics company page
